1 – 10 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden
(
- Contribution to journal › Article
-
Mark
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors : a nationwide direct drug-to-drug comparison
(
- Contribution to journal › Article
-
Mark
Autoantibodies as prognostic markers in rheumatoid arthritis
(
- Contribution to journal › Scientific review
-
Mark
Giant cells in temporal artery biopsies and the risk of large-vessel involvement in patients with giant cell arteritis
(
- Contribution to journal › Scientific review
-
Mark
Disability Related to the Upper Extremities in Early Rheumatoid Arthritis—Long-Term Course and Disease Variable Impact : A Cohort Study
(
- Contribution to journal › Article
- 2024
-
Mark
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis-results from a nested case-control study
(
- Contribution to journal › Article
-
Mark
Special Issue on interstitial lung disease in the setting of rheumatic disorders
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis : Results From a Nationwide Swedish Cohort Study
2024) In Arthritis and Rheumatology(
- Contribution to journal › Article
-
Mark
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies
(
- Contribution to journal › Article
-
Mark
Temporal artery biopsy in giant cell arteritis : clinical perspectives and histological patterns
(
- Contribution to journal › Article